Gaucher's Disease
What is Gaucher's Disease?
Gaucher's disease is a rare genetic disorder that causes fatty substances to build up in certain organs. These substances, called glucocerebrosides, collect primarily in the liver and spleen. They can also accumulate in bone tissue, bone marrow, and sometimes the lungs and brain.
This buildup happens because people with Gaucher's disease lack enough of an enzyme called glucocerebrosidase. Without this enzyme, the body cannot break down these fatty substances properly. The condition is inherited, meaning it passes from parents to children through genes. About 1 in 40,000 people have Gaucher's disease, though it is more common in people of Ashkenazi Jewish descent.
There are three main types of Gaucher's disease. Type 1 is the most common and does not affect the brain or nervous system. Type 2 and Type 3 are rarer and can affect the nervous system. Most people diagnosed in adulthood have Type 1, which can range from mild to severe.
Symptoms
Symptoms of Gaucher's disease vary widely from person to person. Some people experience severe symptoms in childhood, while others have mild symptoms that don't appear until adulthood.
- Enlarged spleen and liver, which can cause abdominal swelling and discomfort
- Fatigue and weakness due to low red blood cell counts
- Easy bruising and bleeding from low platelet counts
- Bone pain, fractures, or bone deterioration
- Joint pain and stiffness
- Yellowing of the skin or eyes
- Delayed growth in children
- Frequent nosebleeds
Some people with Type 1 Gaucher's disease have no symptoms for years or even decades. The condition may only be discovered during routine blood work or imaging tests done for other reasons.
Concerned about Gaucher's Disease? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Gaucher's disease is caused by mutations in the GBA gene. This gene provides instructions for making the glucocerebrosidase enzyme. When both copies of this gene have mutations, the body cannot produce enough working enzyme. This leads to the buildup of fatty substances in cells throughout the body. The condition follows an autosomal recessive pattern, meaning both parents must carry the gene mutation for a child to develop the disease.
Risk factors include having parents who carry the gene mutation and Ashkenazi Jewish ancestry. People with one copy of the mutated gene are carriers and typically do not have symptoms. When two carriers have a child together, there is a 25% chance the child will have Gaucher's disease. Family history of the condition increases risk significantly. While you cannot prevent inheriting the gene mutation, genetic counseling can help families understand their risk.
How it's diagnosed
Diagnosis of Gaucher's disease typically begins with a physical exam and blood tests. Doctors measure enzyme activity in the blood to check glucocerebrosidase levels. Low enzyme activity suggests Gaucher's disease. Genetic testing can confirm the diagnosis by identifying mutations in the GBA gene. Some blood tests may show elevated levels of Angiotensin-1-Converting Enzyme or Prostatic Acid Phosphatase, which can occur due to organ and bone involvement in Gaucher's disease.
Imaging tests like ultrasound, MRI, or X-rays help doctors assess organ enlargement and bone damage. Bone marrow biopsy may be performed in some cases. If you have symptoms or a family history of Gaucher's disease, talk to our doctor about specialized testing and evaluation by a genetic specialist.
Treatment options
Treatment for Gaucher's disease focuses on managing symptoms and preventing complications. The main approaches include:
- Enzyme replacement therapy, which provides the missing enzyme through IV infusions every two weeks
- Substrate reduction therapy, which uses oral medications to reduce production of fatty substances
- Pain management medications for bone and joint pain
- Blood transfusions for severe anemia or low platelet counts
- Bone health support with calcium and vitamin D supplements
- Physical therapy to maintain bone and joint function
- Surgical removal of the spleen in severe cases, though this is rare
- Regular monitoring with blood tests and imaging to track disease progression
Many people with Type 1 Gaucher's disease respond well to treatment and can live normal lives. Working with a specialist experienced in treating Gaucher's disease is important for the best outcomes.
Frequently asked questions
People with Type 1 Gaucher's disease who receive treatment can have a normal life expectancy. Early diagnosis and consistent treatment prevent serious complications that could shorten life. Type 2 is more severe and typically affects life expectancy more significantly. Type 3 falls between Type 1 and Type 2 in terms of severity and prognosis.
Gaucher's disease is not curable because it is a genetic condition. However, treatments like enzyme replacement therapy and substrate reduction therapy can effectively manage symptoms. These treatments allow many people to live healthy, active lives. Gene therapy research is ongoing and may offer future treatment options.
Gaucher's disease is inherited in an autosomal recessive pattern. This means a child must inherit one mutated gene from each parent to develop the disease. If both parents are carriers, each child has a 25% chance of having Gaucher's disease and a 50% chance of being a carrier. Genetic counseling can help families understand their risk.
Yes, Gaucher's disease can be detected through prenatal genetic testing. This is typically offered when both parents are known carriers or have a family history of the condition. Tests like chorionic villus sampling or amniocentesis can identify gene mutations in the developing baby. Genetic counselors can discuss testing options with expecting parents.
The primary diagnostic test measures glucocerebrosidase enzyme activity in blood cells. Low enzyme activity strongly suggests Gaucher's disease. Additional blood tests may show elevated Angiotensin-1-Converting Enzyme or Prostatic Acid Phosphatase levels, which can occur with organ and bone involvement. Genetic testing confirms the diagnosis by identifying specific gene mutations.
People receiving treatment typically need blood tests every 3 to 6 months to monitor disease activity and treatment response. Tests check blood cell counts, enzyme levels, and organ function markers. Imaging tests to assess the liver, spleen, and bones are usually done yearly. Your specialist will create a personalized monitoring schedule based on your disease severity and treatment response.
The first signs in adults are often fatigue and an enlarged spleen discovered during a routine exam. Some people notice easy bruising or frequent nosebleeds due to low platelet counts. Bone pain, especially in the hips and legs, is another common early symptom. Many adults have mild symptoms for years before diagnosis.
While lifestyle changes cannot treat the underlying genetic cause, they can support overall health. Eating a balanced diet rich in calcium and vitamin D supports bone health. Regular low-impact exercise helps maintain bone density and joint flexibility. Avoiding contact sports reduces fracture risk if bones are weakened by the disease.
Research suggests people with Gaucher's disease may have a slightly increased risk of certain cancers, particularly blood cancers like multiple myeloma. The risk remains relatively low overall. Regular monitoring with your doctor helps catch any complications early. Treatment for Gaucher's disease does not increase cancer risk.
Yes, many women with Gaucher's disease have successful pregnancies. However, pregnancy can worsen some symptoms like anemia and low platelet counts. Close monitoring by both a high-risk pregnancy specialist and a Gaucher's disease expert is important. Some treatments can be safely continued during pregnancy, while others may need adjustment.